Skip to content 
Inflammation
The pathogenesis underlying numerous autoimmune diseases originates from the hyperactivity of the immune system, which, instead of protecting the body, begins attacking its tissues. Conditions such as diabetes, rheumatoid arthritis, and systemic lupus erythematosus, among others, are the result of a dysregulated immune system that, in its attempt to defend the body, mistakenly attacks it.
Until recently, therapeutic options for combating the most severe autoimmune diseases were limited. However, it has been demonstrated that therapy based on natural peptide nanoparticles possesses potent anti-inflammatory effects, capable of attenuating and even, in some cases, reversing the clinical signs of these diseases.
The challenge of correcting an autoimmune disease lies in the cyclical nature of immune damage. As the body inflicts damage upon itself, it produces more immune cells that continue attacking without an external pathogen. For example, the knee endures a constant load of daily impact in osteoarthritis, generating stress signals and micro-trauma. In response, the body produces immune cells to degrade and remove the affected tissues. However, this ongoing process leads to an autoimmune attack on healthy tissue, exacerbating the damage.
As the process advances, immune cells invade and destroy essential components such as bones, ligaments, and tendons. Since inflammation is triggered by a specific body region, newly formed immune cells direct their attack toward the local cells, perpetuating a traumatic, inflammatory response. This cycle can have severe and long-term consequences for the patient’s health.
Until a few years ago, pharmaceutical interventions offered few solutions for autoimmune diseases. Although anti-inflammatory drugs have been developed, they cannot restore previously damaged tissue and often present significant long-term side effects. In contrast, therapy with natural nanopeptides represents an advanced and promising therapeutic approach for managing specific autoimmune diseases.
General Preventive Protocol
Devices based on natural nanopeptides halt the progression of autoimmune diseases through two main mechanisms:
- [ 1 ]Nanopeptides have the ability to release growth factors, cytokines, and other bioactive molecules that not only interrupt the inflammatory cascade but also facilitate the regeneration and repair of damaged body tissue.
- [ 2 ]Nanopeptides can differentiate into any of the 205 types of tissues in the human body. This plasticity allows them to replace damaged cells, repair and promote the survival of unaffected cells, and eliminate diseased ones, replacing them with new, healthy cells.
These mechanisms interrupt the inflammatory cascade and ultimately halt the progression of the autoimmune disease.
Nanopeptide therapy offers multiple therapeutic applications for correcting autoimmune diseases, and its safety profile is superior to that of current conventional treatments.